ARG30319
Carcinoma / Sarcoma Antibody Duo
Publication5
Component
| Cat No | Component Name | Host clonality | Reactivity | Application | Package |
|---|---|---|---|---|---|
| ARG62969 | anti-Cytokeratin (pan) antibody [C-11] | Mouse mAb | Hu, Mamm, Ms, Rat | CyTOF®-candidate, FACS, ICC/IF, IHC-P, IP, WB | 50 μg |
| ARG66302 | anti-Vimentin antibody [SQab1859] | Mouse mAb | Chk, Dog, Goat, Hm, Hu, Mk, Ms, Pig, Rat, Xenopus, Zfsh | FACS, ICC/IF, IHC-P, IHC-Fr, WB | 50 μg |
Overview
| Product Description | Carcinoma and sarcoma are two types of cancer from different origins. Carcinoma originates from epithelial cells, whereas sarcoma originates from mesodermal cells. Immunochemistry analysis plays a central role in distinguishing between carcinoma and sarcoma. arigo's Carcinoma/Sarcoma Antibody Duo comprises a carcinoma marker pan-CK antibody and a sarcoma marker Vimentin antibody. Both are mouse monoclonal antibodies with excellent performance on IHC and other application. This antibody panel is an excellent solution for distinguishing between carcinoma and sarcoma. |
|---|---|
| Target Name | Carcinoma / Sarcoma |
| Alternate Names | Carcinoma / Sarcoma antibody; Cytokeratin (pan) antibody; Vimentin antibody |
Properties
| Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
|---|---|
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Specific References
CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene
ARG66302: IHC-P, WB / Mouse
iTRAQ-Based Proteomics Reveals Gu-Ben-Fang-Xiao Decoction Alleviates Airway Remodeling via Reducing Extracellular Matrix Deposition in a Murine Model of Chronic Remission Asthma.
ARG66302: WB / Mouse
Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6.
ARG66302: WB, ICC/IF / Human
P4HA1 as an unfavorable prognostic marker promotes cell migration and invasion of glioblastoma via inducing EMT process under hypoxia microenvironment.
ARG66302: WB / Human
BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
ARG66302: WB, IHC-P / Human
